Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as well as 2-11-2024, 02:00

AkkuShop.de Achieves 300% Increase in Fulfillment Efficiency with Descartes Ecommerce Warehouse Management Solution 14-11-2023, 18:45

Copenhagen Infrastructure Partners Secures Australian Hydrogen Headstart Funding, Strengthening Commitment to Green Ammonia 20-03-2025, 08:30